161 related articles for article (PubMed ID: 1680588)
1. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
2. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Vestn Akad Med Nauk SSSR; 1991; (10):51-4. PubMed ID: 1686950
[TBL] [Abstract][Full Text] [Related]
3. Increase in activating ability of human platelet guanylate cyclase during aggregation.
Severina IS; Belushkina NN
Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
[TBL] [Abstract][Full Text] [Related]
4. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
Chirkov IuIu; Belushkina NN; Tyshchuk IA; Severina IS
Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
[TBL] [Abstract][Full Text] [Related]
5. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
7. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
Severina IS
Adv Enzyme Regul; 1992; 32():35-56. PubMed ID: 1353937
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
Karrenbrock B; Grewe R; Loeschke K; Gerzer R
Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462
[TBL] [Abstract][Full Text] [Related]
9. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
[TBL] [Abstract][Full Text] [Related]
10. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
Matsuoka I; Suzuki T
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison of the effects of nitroprusside, SIN 1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity.
Gerzer R; Karrenbrock B; Siess W; Heim JM
Thromb Res; 1988 Oct; 52(1):11-21. PubMed ID: 2904706
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylyl cyclase is the only enzyme responsible for cyclic guanosine monophosphate synthesis in human platelets.
Gambaryan S; Subramanian H; Rukoyatkina N; Herterich S; Walter U
Thromb Haemost; 2013 May; 109(5):973-5. PubMed ID: 23467662
[No Abstract] [Full Text] [Related]
13. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
14. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
Bussygina OG; Pyatakova NV; Khropov YV; Ovchinnikov IV; Makhova NN; Severina IS
Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
[TBL] [Abstract][Full Text] [Related]
15. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
Severina IS
Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators.
Mellion BT; Ignarro LJ; Ohlstein EH; Pontecorvo EG; Hyman AL; Kadowitz PJ
Blood; 1981 May; 57(5):946-55. PubMed ID: 6111365
[No Abstract] [Full Text] [Related]
17. The synergism of hydrogen peroxide with plasma S-nitrosothiols in the inhibition of platelet activation.
Naseem KM; Chirico S; Mohammadi B; Bruckdorfer KR
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):759-66. PubMed ID: 8836116
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
Homer KL; Wanstall JC
Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
[TBL] [Abstract][Full Text] [Related]
19. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
Severina IS; Bussygina OG; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
[TBL] [Abstract][Full Text] [Related]
20. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
Ferreira MA; do Nascimento NR; de Sousa CM; Pessoa OD; de Lemos TL; Ventura JS; Schattner M; Chudzinski-Tavassi AM
Br J Pharmacol; 2008 Jul; 154(6):1216-24. PubMed ID: 18516074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]